October 16, 2018
United Therapeutics (Nasdaq: UTHR) and MannKind (Nasdaq: MNKD) announced the closing of their pending worldwide exclusive license and collaboration agreement...
April 30, 2018
United Therapeutics (NASDAQ:UTHR) and SteadyMed (NASDAQ:STDY) announced today the signing of a definitive merger agreement under which United Therapeutics will...
April 6, 2018
Sorrento Therapeutics (NASDAQ:SRNE) and Celularity announced today that the companies have started screening patients for its leading CD38 chimeric antigen...
January 23, 2018
Australian stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP), is pleased to announce that the Company has entered into a...
April 6, 2017
Cardiome Pharma (NASDAQ:CRME, TSX:COM) announced its partner SteadyMed Therapeutics (NASDAQ:STDY) successfully completed a clinical validation study of Trevyent.
January 4, 2017
Deep breaths, biotech investors. 2016 was a rough one—but the year ahead looks bright.
November 13, 2016
Last week's top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA.